Literature DB >> 2149885

Impairment by glycation of immunoglobulin G Fc fragment function.

R Dolhofer-Bliesener1, K D Gerbitz.   

Abstract

Incubation of human immunoglobulin G (IgG) with glucose in vitro leads to the formation of glycated IgG concomitant with marked changes in functional properties of the Fc fragment. After 22 days of incubation in the absence and presence of 13.9, 27.7 and 55.5 mmol/l glucose, respectively, protein A binding was reduced by 42, 66 and 83%, depending on the glucose concentration employed. Binding of complement by IgG was abolished after incubation of the immunoglobulins for 13 days at 13.9 mmol/l glucose. In contrast, functional properties of the Fab region were unaffected upon glycation, as revealed by determination of antigen-binding capacity, antibody affinity and antibody concentration. The functional changes of the Fc fragment were observed at glycation levels comparable to those found in diabetics.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2149885     DOI: 10.3109/00365519009091067

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  8 in total

1.  Monitoring nonenzymatic glycation of human immunoglobulin G by methylglyoxal and glyoxal: A spectroscopic study.

Authors:  Praveen K Pampati; Sreekanth Suravajjala; Joel A Dain
Journal:  Anal Biochem       Date:  2010-09-17       Impact factor: 3.365

2.  Effect of Type 2 Diabetes Mellitus and Diabetic Nephropathy on IgG Pharmacokinetics and Subcutaneous Bioavailability in the Rat.

Authors:  Gurkishan S Chadha; Marilyn E Morris
Journal:  AAPS J       Date:  2015-04-30       Impact factor: 4.009

3.  Glycation of CD59 impairs complement regulation on erythrocytes from diabetic subjects.

Authors:  Catherine S Davies; Claire L Harris; B Paul Morgan
Journal:  Immunology       Date:  2005-02       Impact factor: 7.397

4.  Glycation increases the vascular clearance rate of IgG in mice.

Authors:  D M Kennedy; A W Skillen; C H Self
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

5.  Glycation of monoclonal antibodies impairs their ability to bind antigen.

Authors:  D M Kennedy; A W Skillen; C H Self
Journal:  Clin Exp Immunol       Date:  1994-11       Impact factor: 4.330

6.  Matrix-assisted laser desorption/ionization mass spectrometry, enzymatic digestion, and molecular modeling in the study of nonenzymatic glycation of IgG.

Authors:  A Lapolla; D Fedele; M Garbeglio; L Martano; R Tonani; R Seraglia; D Favretto; M A Fedrigo; P Traldi
Journal:  J Am Soc Mass Spectrom       Date:  2000-02       Impact factor: 3.262

7.  Methylglyoxal produces more changes in biochemical and biophysical properties of human IgG under high glucose compared to normal glucose level.

Authors:  Mohd Adnan Khan; Zarina Arif; Mohd Asad Khan; Khursheed Alam
Journal:  PLoS One       Date:  2018-01-19       Impact factor: 3.240

Review 8.  Glycation Damage: A Possible Hub for Major Pathophysiological Disorders and Aging.

Authors:  Maxime Fournet; Frédéric Bonté; Alexis Desmoulière
Journal:  Aging Dis       Date:  2018-10-01       Impact factor: 6.745

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.